US Stock MarketDetailed Quotes

BCAX Bicara Therapeutics

Watchlist
  • 14.945
  • +0.065+0.44%
Trading Apr 30 10:31 ET
814.85MMarket Cap-11.97P/E (TTM)

Bicara Therapeutics Key Stats

Bicara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--------

Unlock Free Earnings Estimates

Bicara Therapeutics Earnings Reports

Read more

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More